Bioprocessing supply chains must deliver materials and therapies safely, rapidly, and compliantly despite demand volatility, capacity constraints, regulatory complexity, and external unknowns. FUJIFILM Biotechnologies addresses these challenges with kojoX™, a modular, data-driven operating model that embeds flexibility, scalability, and resilience across a global bioproduction network. Centered on end-to- end orchestration and supplier collaboration, kojoX integrates strategic stock holding, dual sourcing, consignment inventory, SKU rationalization, and delayed differentiation to maintain agility under uncertainty. By engaging supply chain expertise early and committing to continuous improvement, FUJIFILM Biotechnologies reduces risk, accelerates technology transfer and time-to-market, and ensures reliable, end-to-end supply assurance for customers and the patients they serve. Download the white paper to learn more.

Primary Interest(Required)
This field is hidden when viewing the form
Segments(Required)
This field is hidden when viewing the form
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy